Welcome to your daily briefing on healthcare developments in Mississippi. Today we're covering 5 key stories including updates on mississippi healthcare headlines, background & context. Let's dive in.
2 stories
The Mississippi State Board of Medical Licensure provides a public online portal to verify medical professional licenses.
Healthcare professionals and employers in MS can quickly confirm credential status, supporting compliance and patient safety.
The Mississippi Division of Medicaid transitioned to a new Fiscal Agent on Oct. 3, 2022, introducing MESA (Medicaid Enterprise System Assistance), a new MMIS and provider portal designed to enhance connections between health services systems and improve access to health information.
Healthcare professionals in MS who serve Medicaid patients will need to use MESA for claims, eligibility verification, and other Medicaid transactions, making familiarity with the portal essential to maintaining smooth practice operations.
Reach healthcare professionals
3 stories
A vendor is a business associate if they create, receive, maintain, or transmit PHI on behalf of the covered entity. They are NOT a business associate just because they happen to be in a building with PHI or could conceivably access it. The functional test matters, not the proximity test.
Forcing BAA execution on vendors who do not meet the functional test creates contractual bloat and weakens the negotiating position with vendors who actually do. Failing to execute BAAs with true business associates exposes the covered entity to OCR enforcement.
Three application defects routinely delay payor enrollment: incomplete work-history explanations for any gap over 30 days, a malpractice carrier-history that does not reconcile with the explanation, and CAQH attestation that has lapsed. Each forces a back-and-forth with the credentialing committee.
A new clinician without active payor enrollment cannot bill for covered services for most plans. Each month of delay is foregone revenue that does not retroactively recover.
Covered entities must annually recertify their 340B eligibility through HRSA. Missing the recertification window pushes the entity to inactive status, which means immediate loss of 340B pricing and potentially diversion violations on previously dispensed drugs. Reinstatement requires a new application.
The discount value of 340B pricing for a covered entity often exceeds six figures annually. Letting the recertification lapse for paperwork reasons is one of the most expensive administrative errors in the regulation.
Get Mississippi healthcare intelligence delivered to your inbox every morning.
Subscribe FreeView all past issues
Feature your brand across the U.S., Canada, and select international markets and 10 industry verticals.
Become a National Partner